1. Ngcamphalala C, Östensson E, Ginindza TG. The economic burden of prostate cancer in Eswatini. BMC Health Serv Res. 2022 Apr 11;22(1):483.

2. Ngcamphalala C, Östensson E, Ginindza TG (2021). The economic burden of cervical cancer in Eswatini: Societal perspective. PLoS ONE 16(4): e0250113. 

3. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2):e191-e203.

1. Shamu T, Rohner E, Chokunonga E, Spoerri A, Mandiriri A, Chimbetete C, Egger M, Bohlius J, Borok M. Cancer incidence among people living with HIV in Zimbabwe: A record linkage study. Cancer Reports. 2021 Dec 7:e1597.

2. Gotora E. Health System in Zimbabwe and Delay in Seeking Health Care of Breast Cancer Among Women. Athens Journal of Health and Medical Sciences. 2021 Dec:243-64.

3. Stoeter O, Seraphin TP, Chitsike I, Chokunonga E, Kambugu JB, Wabinga H, Parkin DM, Kantelhardt EJ. Trends in childhood cancer incidence in sub‐Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda). International Journal of Cancer. 2021 Sep 1;149(5):1002-12.

4. Okorie IE, Moyo R, Nadarajah S. The impact of socio-demographic factors on the survival of cancer patients in Zimbabwe. Scientific Reports. 2021 Jun 10;11(1):1-6.

5. Parkin DM, Chingonzoh T, Vuma S, Liu B, Chokunonga E, Ndlovu N, Borok M. Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):867-873.

6. Manyau MC, Mudzviti T, Rusakaniko S, Mberi ET, Maponga CC, Morse GD. Survival of HIV-infected patients with high-grade non-Hodgkin’s lymphomas: A retrospective study of experiences in Zimbabwe. Plos one. 2020 Sep 17;15(9):e0239344.

7. Tangka FK, Subramanian S, Edwards P, Korir AR, Wabinga H, Chokunonga E, Finesse A, Borok MZ, Liu B, Saraiya M, Parkin DM. Cost of operating population-based cancer registries: Results from 4 sub-Saharan African countries. Journal of registry management. 2019;46(4):114.

8. Chokunonga E, Mhlanga FG, Guzha BT, Manyere NR, Chirenje ZM. Trends in reported vulval cancer in Zimbabwe, 2006-2014. Central African Journal of Medicine. 2018;64(10-12):99-103.

9. Kuguyo O, Matimba A, Tsikai N, Magwali T, Madziyire M, Gidiri M, Dandara C, Nhachi C. Cervical cancer in Zimbabwe: a situation analysis. The Pan African Medical Journal. 2017;27.

10. Muchuweti D, Nyandoro G, Muguti E, Muchaziwepi T. Factors contributing to delayed breast cancer presentation: A prospective study at Parirenyatwa group of hospitals, Harare, Zimbabwe 2010-2013. J Cancer Tumor Int. 2017;5:1-0.

1: Patel TA, Schubert FT, Hom MA, Cougle JR. Correlates of treatment seeking in individuals with social anxiety disorder: Findings from a nationally representative sample. J Anxiety Disord. 2022 Oct;91:102616. 

2: Carter SP, Campbell SB, Wee JY, Law KC, Lehavot K, Simpson T, Reger MA. Suicide Attempts Among Racial and Ethnic Groups in a Nationally Representative Sample. J Racial Ethn Health Disparities. 2022 Oct;9(5):1783-1793. 

3: Stevens AK, Gunn RL, Sokolovsky AW, Colby SM, Jackson KM. Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance. Exp Clin Psychopharmacol. 2022 Oct;30(5):701-713. 

4: Thornburg B, Bray JW, Wittenberg E. Health Utility of Drinkers' Family Members: A Secondary Analysis of a US Population Data Set. MDM Policy Pract. 2022 Sep 27;7(2):23814683221128507.

5: Elliott M, Ragsdale JM. Stress exposure and well-being: correlates of meeting criteria for bipolar disorder, borderline personality disorder, or both. Soc Psychiatry Psychiatr Epidemiol. 2022 Sep;57(9):1885-1896. 

6: Nakic M, Stefanovics EA, Rhee TG, Rosenheck RA. Lifetime risk and correlates of incarceration in a nationally representative sample of U.S. adults with non- substance-related mental illness. Soc Psychiatry Psychiatr Epidemiol. 2022 Sep;57(9):1839-1847. 

7: Bommersbach TJ, Rosenheck RA, Petrakis IL, Rhee TG. Why are women more likely to attempt suicide than men? Analysis of lifetime suicide attempts among US adults in a nationally representative sample. J Affect Disord. 2022 Aug 15;311:157-164. 

8. Zhang H, Grant BF, Hodgkinson CA, Ruan W, Kerridge BT, Huang B, Saha TD, Fan AZ, Wilson V, Jung J, Parsian A. Strong and weak cross-inheritance of substance use disorders in a nationally representative sample. Molecular Psychiatry. 2022 Mar;27(3):1742-53.

9. Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015 Aug;72(8):757-66. 

10. Grant BF, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule–Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Version (AUDADIS-5). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2011.

1. Falavigna M, Watanabe SF, Santoro J, Ribeiro K, Schneider N, Safadi M, Stein RT, Kieffer A, Tolardo A. CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private Healthcare System. Value in Health. 2023 Dec 1;26(12):S33.

2. Barbosa A, Magro FJ, Taminato A, Federico P, Prioli RN, Goldflus S, Migliavaca CB, Falavigna M. EE554 Costs Comparison Between Dupilumab and Omalizumab in the Treatment of Severe Allergic Asthma in the Brazilian Private Healthcare Perspective. Value in Health. 2022 Dec 1;25(12):S164.

3. Hjelmgren J, Ericson O, Sjövall F, Söderberg J, Persson I. EE550 The Potential Cost and Cost-Effectiveness Impact of Using Machine Learning Sepsis Prediction Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden and the United Kingdom. Value in Health. 2022 Dec 1;25(12):S163-4.

4. Bighetti Magro FJ, Barbosa A, Taminato A, Borges Migliavaca C, Federico P, Nahuys Tebyriçá R, Cançado JE, Giavina-Bianchi P, Falavigna M. Cost comparison of dupilumab and omalizumab for the treatment of severe allergic asthma patients from the Brazilian private healthcare system perspective. JBES: Brazilian Journal of Health Economics/Jornal Brasileiro de Economia da Saúde. 2022 Dec 1;14(3).

5.Bonilla C, Sortica VA, Schuler-Faccini L, Matijasevich A, Scheffer MC. Medical genetics workforce in Brazil: practitioners, services, and disease distribution. medRxiv. 2021 Oct 18:2021-10.

6. Bonilla C, Sortica VA, Schuler-Faccini L, Matijasevich A, Scheffer MC. Medical genetics workforce in Brazil: practitioners, services, and disease distribution. medRxiv. 2021 Jan 1. (https://www.medrxiv.org/content/10.1101/2021.10.14.21265027v1.full)

7. Julian GS, Carneseca EC, Sicchieri MP. Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State. Value in Health. 2017 Oct 1;20(9):A856.

8. Fahham L, Ueda A, Teich V. Predicting Dengue Fever Outbursts In Brazil: An Empirical Model Based On Climatic Parameters. Value in Health. 2017 Oct 1;20(9):A856.

9. romero Prada ME, Lancheros J, Quiñones PA, Figueroa RM, Peñuela IA, Mendoza F, Diazgranado SH. Costos de la Fibrilación Auricular en Colombia. Value in Health. 2017 Oct 1;20(9):A855-6.

1. Afonso MP, Shimizu HE, Merchan-Hamann E, Ramalho WM, Afonso T. Association between hospitalisation for ambulatory care-sensitive conditions and primary health care physician specialisation: a cross-sectional ecological study in Curitiba (Brazil). BMJ open. 2017 Dec 1;7(12):e015322.

2. Pivovar A, Gonçalves Dos Santos ZF, Torres‐Pereira CC. Oral cancer screening for high‐risk individuals in the primary healthcare setting using an active approach. Journal of Oral Pathology & Medicine. 2017 Oct;46(9):786-91.

For more references, please contact the Curitiba Municipal Health Council.

1.  Ushida T, Yokoyama M, Shiosakai K, Saito K, Ibe S, Okuizumi K. A large-scale database study for the prescription status of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, in Japan. Expert Opin Pharmacother. 2022;23(2):273-283.

2.  Maeda T, Hattori A, Yamamoto J, Tsunekawa K, Ibe S, Kinoshita F. Prescribing Patterns for Anti-Parkinsonian Drugs in Japan: Prescription-Based Database Study. Brain Nerve. 2021;73(3):273-281.

3. Mabuchi T, Hosomi K, Yokoyama S, Takada M. Polypharmacy in elderly patients in Japan: Analysis of Japanese real-world databases. J Clin Pharm Ther. 2020;45(5):991-996. 

4. Ushida T, Matsui D, Inoue T, Yokoyama M, Takatsuna H, Matsumoto T, Takita A, Kurusu T, Sakoda H, Okuizumi K. Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database. Expert Opin Pharmacother. 2019;20(16):2041-2052.

5. Takada M, Fujimoto M, Hosomi K. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases. Int J Med Sci. 2016;13(11): 825–834.

6. Takada M, Fujimoto M, Yamazaki K, Takamoto M, Hosomi K. Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database. Drug Saf. 2014 Aug;37(8):653.

7. Tanaka I, Sato M, Sugihara T, Faries DE, Nojiri S, Graham-Clarke P, et al. Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study, J Osteoporos. 2013;2013:654218.

8. Sato D, Sato Y, Masuda S, Kimura H. Effects of a Sitagliptin Safety Alert on Prescription Behaviour for Oral Antihyperglycaemic Drugs: A Propensity Score-Matched Cohort Study of Prescription Receipt Data in Japan. DrugSaf. 2013;36(8):605-15.

9. Sato D, Sato Y, Masuda S, Kimura H. Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan. Int J Clin Pharm. 2012;34(6):917-24.